先瑞达医疗(06669.HK)一次性导管鞘组Acotrace注册申请获批

阿斯达克财经
30 Oct 2024

先瑞达医疗-B(06669.HK) 公布,收到中国国家药品监督管理局对一次性使用导管鞘组Acotrace的注册批准。公司将适时在内地开展营销活动。Acotrace适用于介入手术中经皮穿刺插入血管系统,用于将导丝、导管类医疗器械插入血管。(de/d)(港股报价延迟最少十五分钟。)

AASTOCKS新闻

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10